Document is current
Any future updates will be listed below
-
Authors
Berntsen, Sine
Zedeler, Anne
Nøhr, Bugge
Rønn Petersen, Morten
Grøndahl, Marie Louise
Andersen, Lars Franch
Løssl, Kristine
Løkkegaard, Ellen
Englund, Anne Lis
Vestergaard Gabrielsen, Anette https://orcid.org/0000-0002-7632-6299
Prætorius, Lisbeth
Behrendt-Møller, Ida
Langhoff Thuesen, Lea
Vomstein, Kilian https://orcid.org/0000-0003-2981-4211
Petri Lauritsen, Mette
Ivanoska Trajcevski, Aleksandra
Frøding Skipper, Dea https://orcid.org/0009-0006-4884-7640
Westergaard, David https://orcid.org/0000-0003-0128-8432
Pinborg, Anja
Svarre Nielsen, Henriette https://orcid.org/0000-0003-2106-8103
la Cour Freiesleben, Nina https://orcid.org/0000-0002-5670-2015
-
Funding
Funding for this research was provided by:
Region Hovedstaden (A6606)
Gedeon Richter (unrestricted grant)
Læge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat (4101466)
- License Information
-
More Information
Article History
Received: 1 October 2024
Accepted: 28 February 2025
First Online: 11 April 2025
Competing interests
: All authors have completed the ICMJE (International Committee of Medical Journal Editors) uniform disclosure form at . K.L., A.P., B.N. and K.V. have received scientific grants and personal payments/honoraria from Gedeon Richter, Ferring Pharmaceuticals and Merck. They have also received support for attending meetings from these companies. A.P. has additionally received consulting fees for lectures and presentations from Novo Nordisk, Cryos and Organon. A.L.E., L.P. and B.N. are on advisory boards for Ferring Pharmaceuticals. B.N. is also on the advisory board for Merck. N.l.C.F. has received scientific grants from Gedeon Richter, Merck and Cryos, and has received consulting fees from Merck and support for meetings from Gedeon Richter, Merck, Ferring Pharmaceuticals and IBSA (Institut Biochimique SA). E.L. received personal payments/honoraria for lectures and presentations from Pfizer and is on the advisory board for Astellas Pharma Nordic. M.L.G. has received scientific grants from Gedeon Richter, Cooper Surgical and Merck, as well as personal payments/honoraria for lectures and presentations from Merck. H.S.N. has received scientific grants from Freya Biosciences, Ferring Pharmaceuticals, BioInnovation Institute, Ministry of Education, Novo Nordisk Foundation, Augustinus Fonden, Oda og Hans Svenningsens Fond, Demant Fonden, Independent Research Fund Denmark and Ole Kirks Fond and has received personal payments/honoraria for lectures and presentations from Ferring Pharmaceuticals, Merck, AstraZeneca, Cook Medical, Gedeon Richter, Novo Nordisk and IBSA. S.B. received scientific grants from Gedeon Richter and Læge Sofus Carl Emil Friis og Hustru Olga Doris Friis’ Fond. A.I.T. received support for attending meetings from Ferring Pharmaceuticals and Gedeon Richter. A.Z., M.R.P., L.F.A., A.V.G., I.B.-M., L.L.T., M.P.L., D.F.S. and D.W. declare no competing interests.
